Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

BioCardia (BCDA) News Today

BioCardia logo
$1.92 +0.03 (+1.59%)
Closing price 08/15/2025 03:59 PM Eastern
Extended Trading
$1.90 -0.02 (-1.04%)
As of 08/15/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

BCDA Latest News

BioCardia and CART-Tech Announce Exclusive Partnership to Develop and Commercialize Heart3D™ Fusion Imaging for Interventional Cardiology
August 13 at 8:51 AM  |  finance.yahoo.comhttps://finance.yahoo.com/news/biocardia-cart-tech-announce-exclusive-120000048.html
BioCardia, Inc. (NASDAQ:BCDA) Q2 2025 Earnings Call Transcript
August 13 at 8:51 AM  |  msn.comhttps://www.msn.com/en-us/money/savingandinvesting/biocardia-inc-nasdaqbcda-q2-2025-earnings-call-transcript/ar-AA1KrAxt
BioCardia Advances Clinical Trials Amid Financial Challenges
August 12, 2025  |  msn.comhttps://www.msn.com/en-us/money/savingandinvesting/biocardia-advances-clinical-trials-amid-financial-challenges/ar-AA1KmqYD
BioCardia, Inc.: BioCardia Reports Second Quarter 2025 Business Highlights and Financial Results
August 12, 2025  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2025-08/66146738-biocardia-inc-biocardia-reports-second-quarter-2025-business-highlights-and-financial-results-399.htm
BioCardia Narrows Loss in Fiscal Q2
August 12, 2025  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/BCDA/pressreleases/34049031/biocardia-narrows-loss-in-fiscal-q2/
BioCardia outlines regulatory milestones and targets FDA and PMDA submissions for CardiAMP and Helix in Q4 2025
August 12, 2025  |  msn.comhttps://www.msn.com/en-us/money/other/biocardia-outlines-regulatory-milestones-and-targets-fda-and-pmda-submissions-for-cardiamp-and-helix-in-q4-2025/ar-AA1Kl4d7
BioCardia, Inc. (BCDA) Q2 2025 Earnings Call Transcript
August 11, 2025  |  seekingalpha.comhttps://seekingalpha.com/article/4812402-biocardia-inc-bcda-q2-2025-earnings-call-transcript
BioCardia Reports Second Quarter 2025 Business Highlights and Financial Results
August 11, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/11/3130983/0/en/biocardia-reports-second-quarter-2025-business-highlights-and-financial-results.html
BioCardia to Host Q2 2025 Corporate Update and Financial Results Conference Call on August 11, 2025
August 6, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/06/3128591/0/en/biocardia-to-host-q2-2025-corporate-update-and-financial-results-conference-call-on-august-11-2025.html
BioCardia Provides Update on Timing of Regulatory Activities Seeking FDA Approval and Japan PMDA Approval for CardiAMP® Cell Therapy for Heart Failure and Helix™ Transendocardial Delivery Catheter
August 4, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/04/3126387/0/en/biocardia-provides-update-on-timing-of-regulatory-activities-seeking-fda-approval-and-japan-pmda-approval-for-cardiamp-cell-therapy-for-heart-failure-and-helix-transendocardial-del.html
Henry Ford Health Initiates Patient Enrollment for BioCardia’s CardiAMP HF II Pivotal Study for Ischemic Heart Failure of Reduced Ejection Fraction
July 16, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/henry-ford-health-initiates-patient-124500218.html
BioCardia, Inc. (NASDAQ:BCDA) CFO David Mcclung Buys 4,819 Shares
July 3, 2025  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-bcda-insider-buying-and-selling-2025-07-03/
BioCardia Announces New United States Patent for Helix Biotherapeutic Delivery System
June 25, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/biocardia-announces-united-states-patent-120000788.html
BioCardia to Participate in Fireside Chat at A.G.P. Virtual Healthcare Company Showcase on May 21, 2025
May 21, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/05/21/3085717/0/en/biocardia-to-participate-in-fireside-chat-at-a-g-p-virtual-healthcare-company-showcase-on-may-21-2025.html
BioCardia, Inc. (BCDA) Q1 2025 Earnings Call Transcript
May 14, 2025  |  seekingalpha.comhttps://seekingalpha.com/article/4786845-biocardia-inc-bcda-q1-2025-earnings-call-transcript
BioCardia Reports First Quarter 2025 Business Highlights and Financial Results
May 14, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/05/14/3081581/0/en/biocardia-reports-first-quarter-2025-business-highlights-and-financial-results.html
BioCardia to Host Q1 2025 Corporate Update and Financial Results Conference Call on May 14, 2025
May 9, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/05/09/3078541/0/en/biocardia-to-host-q1-2025-corporate-update-and-financial-results-conference-call-on-may-14-2025.html
BioCardia Initiates Patient Enrollment For CardiAMP HF II Trial
May 8, 2025  |  nasdaq.comhttps://www.nasdaq.com/articles/biocardia-initiates-patient-enrollment-cardiamp-hf-ii-trial
Insider Buying Surges in May. Especially These 5 Stocks
May 7, 2025  |  247wallst.comhttps://247wallst.com/investing/2025/05/07/insider-buying-surges-in-may-especially-these-5-stocks/?utm_source=snapi
BioCardia Initiates Patient Enrollment at University of Wisconsin at Madison for Ongoing CardiAMP HF II Pivotal Study
May 6, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/biocardia-initiates-patient-enrollment-university-120000997.html
BioCardia, Inc. (NASDAQ:BCDA) Director Bill Facteau Purchases 13,123 Shares
April 26, 2025  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-bcda-insider-buying-and-selling-2025-04-26/
BioCardia, Inc.: BioCardia Announces Positive DSMB Review of CardiALLO Allogeneic Cell Therapy for Heart Failure Phase 1/2 Clinical Trial
April 17, 2025  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2025-04/65123859-biocardia-inc-biocardia-announces-positive-dsmb-review-of-cardiallo-allogeneic-cell-therapy-for-heart-failure-phase-1-2-clinical-trial-399.htm
Alliance Global Partners Sticks to Its Buy Rating for BioCardia (BCDA)
April 17, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/alliance-global-partners-sticks-to-its-buy-rating-for-biocardia-bcda-1034596524
BioCardia announces independent DSMB recommended CardiALLO-HF trial to continue
April 15, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/biocardia-announces-independent-dsmb-recommended-cardiallo-hf-trial-to-continue-1034586507
BioCardia Announces Positive DSMB Review of CardiALLO Allogeneic Cell Therapy for Heart Failure Phase 1/2 Clinical Trial
April 15, 2025  |  tmcnet.comhttps://www.tmcnet.com/usubmit/2025/04/15/10177434.htm
BioCardia initiates enrollment at Emory University for CardiAMP HF II study
April 11, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/biocardia-initiates-enrollment-at-emory-university-for-cardiamp-hf-ii-study-1034575660
BioCardia Initiates Patient Enrollment at Emory University School of Medicine for Ongoing CardiAMP HF II Pivotal Study
April 11, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/04/11/3060107/0/en/biocardia-initiates-patient-enrollment-at-emory-university-school-of-medicine-for-ongoing-cardiamp-hf-ii-pivotal-study.html
Earnings call transcript: BioCardia Q4 2024 sees reduced expenses, stock down
April 2, 2025  |  uk.investing.comhttps://uk.investing.com/news/transcripts/earnings-call-transcript-biocardia-q4-2024-sees-reduced-expenses-stock-down-93CH-4006804
BioCardia’s CardiAMP-HF trial primary endpoint did not reach significance
April 1, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/biocardia-s-cardiamp-hf-trial-primary-endpoint-did-not-reach-significance-1034533513
BioCardia, Inc. (BCDA) Q4 2024 Earnings Call Transcript
March 31, 2025  |  seekingalpha.comhttps://seekingalpha.com/article/4772113-biocardia-inc-bcda-q4-2024-earnings-call-transcript
BioCardia's Conference Call Today, Monday, March 31, 2025 to be Held at 4:30PM EDT Time Today
March 31, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/03/31/3052661/0/en/biocardia-s-conference-call-today-monday-march-31-2025-to-be-held-at-4-30pm-edt-time-today.html
BioCardia Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
March 28, 2025  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/biocardia-full-2024-earnings-eps-110248237.html
BioCardia Reports 2024 Business Highlights and Financial Results
March 26, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/03/26/3050158/0/en/biocardia-reports-2024-business-highlights-and-financial-results.html
BioCardia, Inc. to Report 2024 Financial Results and Host Conference Call Following CardiAMP-HF Trial Presentation
March 23, 2025  |  nasdaq.comhttps://www.nasdaq.com/articles/biocardia-inc-report-2024-financial-results-and-host-conference-call-following-cardiamp-hf
BioCardia to Host 2024 Financial Results and Corporate Update Conference Call on March 31, 2025
March 21, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/03/21/3047049/0/en/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025.html
BioCardia, Inc. Secures Japanese Patent for Innovative Catheter Delivery System in Cell Therapy
March 12, 2025  |  nasdaq.comhttps://www.nasdaq.com/articles/biocardia-inc-secures-japanese-patent-innovative-catheter-delivery-system-cell-therapy
BioCardia announces Japanese patent for Helix system
March 10, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/biocardia-announces-japanese-patent-for-helix-system-1034459339
BioCardia Announces Japanese Patent for Helix™ Biotherapeutic Delivery System
March 10, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/03/10/3039819/0/en/biocardia-announces-japanese-patent-for-helix-biotherapeutic-delivery-system.html
Simon H. Stertzer Acquires 22,753 Shares of BioCardia, Inc. (NASDAQ:BCDA) Stock
March 6, 2025  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-bcda-insider-buying-and-selling-2025-03-06/
BioCardia Completes Source Data Verification for Phase 3 CardiAMP HF Study on Heart Failure Treatment
March 1, 2025  |  nasdaq.comhttps://www.nasdaq.com/articles/biocardia-completes-source-data-verification-phase-3-cardiamp-hf-study-heart-failure
BioCardia finishes data freezing in heart failure therapy study for presentation
February 27, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/biocardia-finishes-data-freezing-in-heart-failure-therapy-study-for-presentation-1034419167
BioCardia Announces Primary Outcome Measures Data Freeze in CardiAMP Heart Failure Trial for Presentation at the American College of Cardiology 2025 Scientific Sessions
February 27, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/02/27/3033949/0/en/biocardia-announces-primary-outcome-measures-data-freeze-in-cardiamp-heart-failure-trial-for-presentation-at-the-american-college-of-cardiology-2025-scientific-sessions.html
BioCardia completes enrollment for heart therapy trial
February 14, 2025  |  msn.comhttps://www.msn.com/en-us/health/other/biocardia-completes-enrollment-for-heart-therapy-trial/ar-AA1yZhcP
BioCardia completes enrollment in low dose cohort in CardiALLO Phase I/II trial
February 13, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/biocardia-completes-enrollment-in-low-dose-cohort-in-cardiallo-phase-i-ii-trial-1034356690
BioCardia Reports Completion of Low Dose Cohort Enrollment for CardiALLO Phase I/II Clinical Trial of BCDA-03 Allogeneic Mesenchymal Stem Cells to Treat Ischemic Heart Failure of Reduced Ejection Fraction (HFrEF)
February 13, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/02/13/3025883/0/en/biocardia-reports-completion-of-low-dose-cohort-enrollment-for-cardiallo-phase-i-ii-clinical-trial-of-bcda-03-allogeneic-mesenchymal-stem-cells-to-treat-ischemic-heart-failure-of-r.html
Biocardia CEO Peter Altman acquires $1,488 in common stock
February 11, 2025  |  msn.comhttps://www.msn.com/en-us/health/other/biocardia-ceo-peter-altman-acquires-1488-in-common-stock/ar-AA1yQZ6n
Biocardia CEO Peter Altman acquires $1,488 in stock
February 11, 2025  |  msn.comhttps://www.msn.com/en-us/money/general/biocardia-ceo-peter-altman-acquires-1-488-in-stock/ar-AA1yR6aO
BioCardia upgraded to Buy from Neutral at Alliance Global Partners
January 31, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/biocardia-upgraded-to-buy-from-neutral-at-alliance-global-partners-1034289030
BioCardia, Inc. Announces Presentation of CardiAMP HF Phase 3 Study Results at ACC 2025 Scientific Sessions
January 29, 2025  |  nasdaq.comhttps://www.nasdaq.com/articles/biocardia-inc-announces-presentation-cardiamp-hf-phase-3-study-results-acc-2025-scientific
BioCardia To Present Late-Breaking CardiAMP HF Trial Results At ACC 2025
January 29, 2025  |  nasdaq.comhttps://www.nasdaq.com/articles/biocardia-present-late-breaking-cardiamp-hf-trial-results-acc-2025
Get BioCardia News Delivered to You Automatically

Sign up to receive the latest news and ratings for BCDA and its competitors with MarketBeat's FREE daily newsletter.

BCDA Media Mentions By Week

BCDA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BCDA
News Sentiment
▼
0.61

0.62
▲
Average
Medical
News Sentiment

BCDA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BCDA Articles
This Week
▼
14

1
▲
BCDA Articles
Average Week

Get BioCardia News Delivered to You Automatically

Sign up to receive the latest news and ratings for BCDA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies
Headlines Tools

This page (NASDAQ:BCDA) was last updated on 8/16/2025 by MarketBeat.com Staff
From Our Partners
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsored
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
"I'm risking my reputation on this"
A massive supply shock is building in the crypto market that could send Bitcoin to $300,000 this year. That...
Crypto 101 Media | Sponsored
When the levee breaks
The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...
Porter & Company | Sponsored
But this $20 American company could control the secret
The "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...
The Oxford Club | Sponsored
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...
Brownstone Research | Sponsored
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsored
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond
Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...
Weiss Ratings | Sponsored